New Research on : Pharmaceutical Contract Manufacturing Market – Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2012 – 2018 Now at Transparency Market Research

Pharmaceutical Contract Manufacturing MarketThe global pharmaceutical contract manufacturing (PCM) market is believed to hold huge opportunities in the future. With economic constraints in European countries, global pharma manufacturing companies are facing extensive cost containment pressures. As a result, pharmaceutical companies are compelled to explore ways to reduce the cost of drug manufacturing.

Thus, a majority of the global drug companies have begun to outsource their manufacturing facilities. Despite the economic pressures faced by pharma companies worldwide, it is expected that the global PCM market will undergo positive growth in the next five years. However, owing to an economic slow-down in European countries, major pharma and biotechnology companies are set to cut down on their spending, resulting in them approaching contract manufacturers across the world.

Browse Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-contract-manufacturing.html

The global pharmaceutical market is undergoing drastic changes because of factors such as increase in generic market competition, decline in R&D productivity, reduction in patent tenure, and growing government restraints, forcing pharmaceutical and biotechnology companies to reduce drug prices. Moreover, an average drug development process takes ten to fifteen years until the commercialization of such a drug and the cost involved in this process is around USD 1 billion.

With a limited number of blockbuster drugs, it has become necessary for pharmaceutical companies to conduct faster drug development with corresponding cost containment. After the procurement of regulatory approval for the drug, the pharma companies have to meet the short deadlines to deliver the drug in the market in large quantities. This has resulted in outsourcing of manufacturing facilities to PCMs.

Outsourcing of manufacturing activities to PCMs enables pharma companies to focus on its R&D activities and harness the wide service range offered by them. The U.S. is the largest market for PCM followed by Europe. Large scale growth is expected in the Asia-Pacific market owing to development it its industrial infrastructure and increase in the incentives offered by the governments.

The big names in the global PCM market are Althea Technologies. HAUPT Pharma AG, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Dishman Pharmaceuticals and Chemicals Limited, NextPharma, Kemwell Pvt. Ltd., Nipro Corp., and Royal DSM N.V.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Latest Upcoming Pharmaceutical Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Transparency Market Research Blog @ : 

http://www.tmrmarketresearch.blogspot.com/

Advertisements

Market Research on : Antiemetic Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019 : Now at Transparency Market Research

Antiemetics are therapeutic agents which are used to treat vomiting and nausea caused by several medical conditions. Nausea and vomiting are not diseases, they are symptoms associated with a variety of medical conditions such as gastroenteritis, motion sickness, dizziness, pregnancy, overeating, emotional stress and food poisoning. Nausea is a condition of unease in the stomach with an involuntary desire to vomit, this often occurs before vomiting. Various antiemetics used to treat vomiting and nausea are dolasetron, olanzapine, alizapride, cyclizine, promethazine and lorazepam. Some of the commercially available brands of antiemetics are Phenergan (promethazine) by Baxter Healthcare Corporation and Zyprexa (olanzapine) by Eli Lilly.

Browse Report @ : http://www.transparencymarketresearch.com/antiemetic-drugs-market.html

The market for antiemetics is segmented on the basis of different class of drugs used to treat emesis and nausea such as 5-HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonists, anticholinergics and others. 5HT3 receptor antagonists act by blocking serotonin receptors in the central nervous system and gastrointestinal tract and comprises of dolastron, ondansetron and tropistron. Dopamine antagonists include domperidone, olanzapine and alizapride while aprepitant and casopitant are NK1 receptor antagonists.

The market for antiemetic drugs is projected to grow worldwide under the influence of increasing incidences of cancer, increased number of surgical procedures being conducted worldwide and other diseases. As mentioned earlier nausea and vomiting are not diseases but they are symptoms and side effects of a variety of diseases including cancer, gastroenteritis, surgeries and early stages of pregnancy. The market of antiemetic drugs will experience along with the increasing incidences of the aforementioned diseases. Nausea is one of the major symptoms caused by motion sickness, if the motion responsible for nausea is not resolved, it will result into vomiting. Extensive travelling causing motion sickness is also one of the major factors driving the growth of the market. The market is growing the fastest in Asia-Pacific due to large number of patients suffering from cancer, gastroenteritis and other diseases causing nausea and vomiting.

Some of the market players in this industry are Pfizer, Baxter International, GlaxoSmithKline, Sanofi, Novartis AG, Merck & Co., Astellas Pharma, Inc., Eli Lilly, Johnson& Johnson, Bristol-Myers Squibb and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Latest Upcoming Pharmaceutical Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Transparency Market Research Blog @ :

http://www.tmrmarketresearch.blogspot.com/

Latest Study Research Report : Central Nervous System Disorder Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019 : Now at Transparency Market Research

The market for central nervous system disorder drugs comprise of drugs used for the treatment of diseases affecting the brain or spinal cord such as epilepsy, Parkinson’s disease, Alzheimer’s disease, depression, anxiety and bipolar disorders. Epilepsy is a chronic brain disorder characterized by recurring seizures. Parkinson’s disease is a degenerative CNS disorder associated with symptoms including tremor, rigidity, akinesia and bradykinesia. It is reported by Parkinson’s disease Foundation that as of now 7-10 million people are affected with Parkinson’s disease across the globe. These diseases are generally caused by neurodegeneration, autoimmune disorders, trauma, tumors and vascular disorders.

 
The market for CNS disorders is categorized into three segments namely psychiatry, neurology and pain drugs market. Psychiatry drugs market is further segmented into anxiety, depression, bipolar disorders, schizophrenia and ADHD (attention deficit hyperactivity disorder). Neurology drugs market is divided into migraine, epilepsy, Parkinson’s disease, multiple sclerosis, narcolepsy and and Alzheimer’s disease. Pain management drugs market segment comprises of drugs used to treat pain associated with CNS disorders. Among these psychiatry segment holds the largest share accounting for more than 40% followed by neurology and pain segment.
 
Rapidly increasing geriatric population base resulting in an elevated incidence levels of CNS disorders such as Alzheimer’s disease, Parkinson’s disease, schizophrenia and multiple disorders is one of the key factors driving the growth of the market for CNS disorders.. Currently, there is no drug to cure Alzheimer’s disease, the available medicines only treat the severity of symptoms and improve the quality of life to some extent. That is why companies such as Eli Lilly, Baxter International and Novartis AG are investing heavily in research and development in order to accelerate the treatment of Alzheimer’s disease. Geographically, North America holds the largest share of the total market of CNS disorders followed by Europe and Asia-Pacific. Asia-Pacific is projected to grow at a CAGR more than other regions on account of high prevalence of diseases such as epilepsy, Parkinson’s disease and Alzheimer’s disease. As of 2012, WHO (world health organization) suggests that around 50 million people are suffering from epilepsy worldwide, most of them (approximately 80%) belong to developing nations.
 
Some of the key players operating in the market for CNS disorders are Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis AG, Sanofi, Merck & Co., Abbott Laboratories, Eli Lilly, UCB, Bristol-Meyers Squibb Co. and Astellas Pharma, Inc.
 
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
 
 
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email : sales@transparencymarketresearch.com

New Report : Psychotherapeutic Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Psychotherapeutic drugs market is comprised of drugs which are used to treat mental illnesses such as confused thinking, extreme mood swings, long lasting depression, social withdrawal and suicidal thought. Commonly found mental disorders are schizophrenia, bipolar disorder, anxiety and depression. Schizophrenia is a mental disease associated with hearing voices, unorganized speech and broken thoughts. Depression is a common disorder characterized by lack of confidence, pleasure and interest.

Browse Report @ : http://www.transparencymarketresearch.com/psychotherapeutic-drugs-market.html

The global Psychotherapeutic Drugs Market is segmented on the basis of various therapeutic classes used to treat mental illness such as antipsychotics (chlorpromazine, haloperidol), antidepressants (amitriptyline, clomipramine), antimaniacs (lithium, carbamazepine) and anxiety drugs (lorazepam, alprazolam). Antipsychotic is one of the fastest growing segments owing to increasing incidences of mental disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics are the most preferred antipsychotics because they are more efficacious than first generation antipsychotics. Top selling antipsychotic drugs are Abilify, Seroquel, Risperdal and Zyprexa.

The global psychotherapeutic drugs market is growing worldwide due to high prevalence of emotional and mental diseases. According to WHO report approximately 350 million people are suffering from depression and around 24 million people are affected by schizophrenia around the world as of today. Patent expiration of top psychotic drugs Prozac, Geodon and Zyprexia has opened way for generic manufacturers and it is expected that in coming years generic segment will rise dramatically and will give rise price competition in the psychotherapeutic drugs market.

America has been the largest market accounting for more than 40% of the total psychotherapeutic drugs market owing to high incidences of schizophrenia and depression among baby boomers. It is predicted that the market will witness rapid growth in Asia-Pacific under the influence of changing life style, disease awareness and growing aging population.
The key players operating in this market are Eli Lilly, Bristol-Meyer Squibb, GlaxoSmithKline, Pfizer, Astrazeneca, Astellas Pharma Inc., Wyeth and Johnson & Johnson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

Latest Upcoming Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com 

Transparency Market Research Blog @ : https://tmrmarketresearch.wordpress.com

Latest Reports – Hypercholesterolemia Partnering 2007-2013 : Now at Market Research Industry

Hypercholesterolemia Partnering 2007-2013 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of hypercholesterolemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hypercholesterolemia technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases do not.

Browse Report @ : http://www.marketresearchindustry.com/report/hypercholesterolemia-partnering-2007-170800.html

Table of Content 

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in hypercholesterolemia partnering
2.1. Introduction
2.2.Hypercholesterolemia partnering over the years
2.3. Bigpharma hypercholesterolemia dealmaking activity
2.4. Hypercholesterolemia partnering by deal type
2.5. Hypercholesterolemia partnering industry sector
2.6. Hypercholesterolemia partnering by stage of development
2.7. Hypercholesterolemia partnering by technology type
2.8. Disclosed financial deal terms for hypercholesterolemia partnering
2.8.1 Hypercholesterolemia headline values
2.8.2 Hypercholesterolemia upfront payments
2.8.3 Hypercholesterolemia milestone payments
2.8.4 Hypercholesterolemia royalty rates

Chapter 3 Leading hypercholesterolemia deals
3.1. Introduction
3.2. Top hypercholesterolemia deals by value
3.3. Top hypercholesterolemia deals involving bigpharma

New Report : Computer Aided Detection Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Computer Aided Detection MarketComputer aided detection (CADe) assists radiologists in interpretation of medical images effectively. This is also known as computer aided diagnosis (CADx). These procedures help radiologists and doctors to evaluate and analyze the information yielded by various imaging techniques such as MRI, X-ray and ultrasound diagnostics. CAD technology is a combination of digital image processing, radiological image processing and artificial intelligence. These systems scan the typical appearances/images and highlight evident sections which may be the symptoms of possible diseases. This procedure aids in accurate interpretation of images with the help of automated process via CAD algorithms.

Browse Report @http://www.transparencymarketresearch.com/computer-aided-detection.html

The technology is still in its infant stage and holds immense growth potential in the near future. It is employed in the detection of breast, lung, prostate and other cancers. For example, CAD in mammography highlights hyperdense structures and micro calcification clusters present in the soft tissue. Breast cancer detection dominates this market due to the increasing installations of these systems in ultrasound, MRI and mammography applications.

With technological advances and introduction of innovative products in the market, lung and colon cancer detection is gaining further recognition followed by breast cancer detection. There has been a trend of enhanced adoption of CAD systems in diagnostic imaging due to emergence of advanced digital imaging techniques and high efficiency of CAD solutions. The computer aided detection market can be segmented on the basis of application, technology and geography. The application segment includes CAD systems which aid in diagnosis of breast, lung, cardiovascular, neurology and musculoskeletal related disorders. Nuclear imaging, ultrasound, MRI and computed tomography are included in the technology segment.
The CAD market is gaining momentum due to the development of integrated CAD systems with multiple modalities, better display aspects, ease of manipulability of image, management speed and image viewing. The FDA’s release of guidelines for manufacturers on clinical study requirements and approval of CAD systems (devices and software), further paves the path for development of innovative solutions in this arena. However, economic fluctuations, less availability and accessibility of these systems might hamper the growth of the market. At present, manufacturers are focusing on the development and upgradation of existing CAD softwares in order to enhance the efficiencies of these systems. For better decision making, there is a demand for inclusion of patient information, such as medical history and prior diagnoses, and integration of the image database as a reference for radiologists. Invivo Corporation, Siemens Healthcare, Hologic, Inc., Medipattern Corporation, Viatronix, Inc. and Philips Healthcare are some of the leading manufacturers involved in the development of CAD devices and software.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

Upcoming Market Research Reports @ : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About Us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

New Report : Biosimilar Opportunities Evolving Market – Market Research Industry

The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products. But what products can be expected to follow, who is developing them and what are the hot prospects?
Biosimilars: another milestone passed
 
At the end of June 2013, the European Medicines Agency’s Committee for Medical Products for Human Use issued a positive opinion for the first biosimilar version of Johnson & Johnson’s infliximab for the treatment of rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis. For the two successful applicants, Celltrion and Hospira, this development passes a significant milestone for the whole biosimilar sector as the products are the first monoclonal antibody (mAb) therapies to reach a positive opinion following review via the EMA biosimilars regulatory pathway. This is an important event which heralds a new era of lower-cost biological therapies in Europe.
Table of Content
 
Foreword & Executive Summary
  • Biosimilars: What Are They and Why
  • Are We Interested?
  • What Is A Biotech Drug?
  • Biosimilars and Biobetters Defined
Product Analysis Each product review which follows covers, where appropriate,
  • Developer/Background
  • Mode of Action
  • Approvals
  • Competition within the Marketplace
  • Patents
  • Sales Trends
First Generation Biosimilars Erythropoietin
  • Epogen/Eprex/Procrit (epoetin alfa)
  • Aranesp (darbepoetin alfa)
  • NeoRecormon (epoetin beta)
  • Mircera (methoxy polyethylene glycolepoetin beta) Biosimilar Erythropoietin
  • Europe
  • USA
  • Rest of the World (Epoetin & Darbepoetin)
  • G-CSF
  • Neupogen (filgrastim)
  • Neulasta (pegfilgrastim)
  • Neutrogin/Granocyte (lenograstim)
  • Biosimilar G-CSF
  • Europe (Filgrastim and Pegfilgrastim)
  • USA
  • Rest of the World